Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001971857-24-000013
Filing Date
2024-01-02
Accepted
2024-01-02 17:47:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3410
  Complete submission text file 0001971857-24-000013.txt   4822
Mailing Address 343 OYSTER POINT BLVD SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address
Goeltz II Robert C. (Reporting) CIK: 0001653881 (see all company filings)

Type: 144

Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Subject) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38419 | Film No.: 24503722
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)